WuXi AppTec
WuXi AppTec
WuXi AppTec is a global pharmaceutical, biopharmaceutical, and medical device outsourcing company.
WuXi AppTec, founded in December, 2000 and headquartered in Wuxi, is Ge Li. The founder is Ge Li. Listed on the HKEX on December 13, 2018, the company's major shareholders are HKSCC Nominees Ltd, G&C VI Ltd and Summer Bloom Investments (I) PTE. Ltd. Rivals that have direct and indirect competition with WuXi AppTec include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.
- All
- News
- Analysis
- Research
In depth
Briefing Aug 12, 2021 06:34 PM
· Healthcare
Wuxi apptec: the revenue in the first half of the year was 10.537 billion yuan, a year-on-year increase of 45.7%
Research
Technology, Consumer Staples, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Research
Industrials, Financials, AutomotiveTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Research
Industrials, Financials, AutomotiveLow-Carbon Industry Expansion - Key Studies From Chinese Companies
May 28, 2020 12:40 PM
Briefing Jul 21, 2021 09:36 PM
· Financials
In the second quarter, the public fund's heavy position stocks are released, and Guizhou Maotai is still the largest heavy position stocks
Healthcare
Revenue and Net Profit of Wuxi Apptec Both Increased in 2020
Wuxi apptec said that the main reasons for the company's performance growth were the high growth of laboratories in China and the year-on-year growth of CDMO plate. China laboratory service is the core business of Wuxi apptec, accounting for more than 50% of its revenue. Its main business is small molecule drug discovery, drug analysis and testing.
Apr 01, 2021 04:39 PM
Briefing Jul 12, 2021 10:20 AM
Cro concept stocks rebounded across the board, and Boteng shares rose 14%
Briefing Jul 06, 2021 10:59 AM
· Healthcare
Blu ray development responds that Huaxia Bank and Vanke will take shares: unconfirmed market rumors
Briefing Jun 15, 2021 08:07 PM
· Healthcare
Wuxi apptec's regulatory letter to Shanghai Stock Exchange: shareholders are required to formulate compensation measures as soon as possible
See more
Related Companies
EqualOcean Analysis
- Four Growing Stocks to Watch in the Dynamic Chinese Market
- Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
- China Speed: Two COVID-19 Vaccines Recognized by WHO
- After China's BNR and GTH Hit Nasdaq, Pan-Cancer Detector GRAIL Eyes IPO
- Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.